BioCentury
ARTICLE | Company News

DynPort, U.K. Ministry of Defence infectious news

October 11, 2010 7:00 AM UTC

DynPort received a nine-month $987,888 contract from the U.K.'s Ministry of Defence to explore the regulatory pathway for approval of DynPort's rF1V plague vaccine candidate in EU. DynPort and ERA C...